Dianthus Therapeutics, Inc. (DNTH)
108.02
+1.78
(+1.68%)
USD |
NASDAQ |
Sep 03, 13:40
Dianthus Therapeutics Research and Development Expense (TTM) : 175.60M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 175.60M |
| March 31, 2026 | 153.16M |
| December 31, 2025 | 145.64M |
| September 30, 2025 | 112.16M |
| June 30, 2025 | 105.21M |
| March 31, 2025 | 97.03M |
| December 31, 2024 | 83.10M |
| September 30, 2024 | 65.47M |
| June 30, 2024 | 47.89M |
| March 31, 2024 | 40.07M |
| December 31, 2023 | 32.84M |
| September 30, 2023 | 33.89M |
| June 30, 2023 | 33.15M |
| March 31, 2023 | 33.30M |
| December 31, 2022 | 42.79M |
| September 30, 2022 | 45.54M |
| June 30, 2022 | 48.59M |
| March 31, 2022 | 48.83M |
| Date | Value |
|---|---|
| December 31, 2021 | 44.75M |
| September 30, 2021 | 43.93M |
| June 30, 2021 | 44.96M |
| March 31, 2021 | 46.42M |
| December 31, 2020 | 48.64M |
| September 30, 2020 | 55.10M |
| June 30, 2020 | 60.34M |
| March 31, 2020 | 61.66M |
| December 31, 2019 | 58.72M |
| September 30, 2019 | 52.88M |
| June 30, 2019 | 47.78M |
| March 31, 2019 | 44.03M |
| December 31, 2018 | 41.34M |
| September 30, 2018 | 34.50M |
| June 30, 2018 | 28.29M |
| March 31, 2018 | 32.43M |
| December 31, 2017 | 27.90M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Legend Biotech Corp. | 397.18M |
| Ironwood Pharmaceuticals, Inc. | 86.86M |
| Verastem, Inc. | 140.22M |
| Fortress Biotech, Inc. | 1.186M |
| AbbVie, Inc. | 9.714B |